Vitaprost tab n / an kish.rastv. 20mg 20 pc

Description

Composition
Active substance:
Prostate Extract – 100 mg (relative to water soluble peptides – 20 mg) ;.
Excipients:
Sucrose – 28,500 mg lactose monohydrate – 7,125 mg calcium stearate monohydrate – 2,500 mg, crospovidone – 9.275 mg Microcrystalline cellulose – to 102.600 mg;
shell composition: acryl-of (methacrylic acid and ethyl acrylate copolymer [1: 1], titanium dioxide, talc, triethyl citrate, colloidal silicon dioxide, sodium hydrogencarbonate, sodium lauryl sulfate, indigo carmine) – 25 mg.
Description:
Pills from blue to light blue, round, biconvex, allowed the presence of inclusions.
Product form:
The tablets, enteric-coated tablets, 20 mg. 10 tablets in blisters. One, two or three blisters with instruction for medical use the drug is placed in a cardboard pack.
Contraindications
Hypersensitivity to the drug. Lactase deficiency, deficit sucrase / isomaltase, lactose intolerance, fructose intolerance, glucose-galactose malabsorption (formulation contains lactose and sucrose).
Dosage
20 mg
Indications
Chronic abacterial prostatitis.
Prevention of exacerbations of chronic nonbacterial prostatitis.
Benign prostatic hyperplasia.
The state before and after surgical interventions on the prostate gland.
Interaction with other drugs
If you are taking any other medications before starting treatment should consult a doctor.
Cases interaction or incompatibility described with other drugs.
Overdose
No cases of overdose have been reported.
pharmachologic effect
Pharmacological group:
Chronic prostatitis is a treatment.
Pharmacological properties:
Vitaprost® has Organotropona action on the prostate. Reduces the degree of swelling, leukocytic infiltration prostate, normalizes the secretory function of epithelial cells, increases the number of lecithin granules secret acini, stimulates the muscle tone of the bladder. Improves microcirculation in the prostate by reducing thrombus formation, antiplatelet activity, prevents the development of thrombosis in the prostate gland venules.
Based on clinical trial data demonstrated that Vitaprost® moderately reduces the volume of the prostate. The drug reduces the severity of obstructive and irritative symptoms of benign prostatic hyperplasia, which results in increasing the maximum and average volumetric flow rates of urine and decrease residual urine volume.
These clinical studies have shown that use of the drug Vitaprost® reduces the likelihood of exacerbations of chronic nonbacterial prostatitis, does not cause changes in indicators of clinical and biochemical blood tests, urinalysis. Vitaprost® efficacy of the drug for prevention of exacerbations of chronic abacterial prostatitis estimated medical researchers is 97.5%.
Vitaprost® normalizes the secretion of the prostate and the parameters of the ejaculate. It reduces pain and discomfort caused by prostatitis, eliminating dysuria, improves the copulatory function.
Conditions of supply of pharmacies
Without a prescription.
side effects
Extremely rare – allergic reactions.
If any of the above side effects are compounded or you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
Treatment of chronic prostatitis and states before and after surgery on the prostate gland is to be integrated, along with the assignment presupposes Vitaprost® tablets application of other groups of drugs and non-drug therapies.
It does not affect the ability to drive and other mechanisms.
Storage conditions
At temperatures above 25 ° C. Keep out of the reach of children.
Dosing and Administration
Inside, 1 tablet 2 times a day.
Duration of treatment with drug Vitaprost® benign prostatic hyperplasia – not less than 30 days of chronic prostatitis – not less than 10 days.
For the prevention of exacerbations of chronic prostatitis use 1 tablet 2 times a day for at least 30 days – 1-2 times a year.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist